Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02366728
Title C Migration Study for Newly-Diagnosed GBM (ELEVATE)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gary Archer Ph.D
Indications

high grade glioma

Therapies

pp65 Dendritic Cell Vaccine + Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.